PEAR THERAPEUTICS
Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform combines novel digital interventions with drugs to enhance efficacy well beyond anything that is commercially available or in clinical development, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective services for payors.
PEAR THERAPEUTICS
Industry:
Biotechnology MHealth Pharmaceutical Software Therapeutics
Founded:
2013-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.peartherapeutics.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
409 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Nginx
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Trustbridge Partners
Trustbridge Partners investment in Post-IPO Equity - Pear Therapeutics
Pritzker/Vlock Family Office
Pritzker/Vlock Family Office investment in Post-IPO Equity - Pear Therapeutics
Health Innovation Capital
Health Innovation Capital investment in Post-IPO Equity - Pear Therapeutics
The Eleven Fund
The Eleven Fund investment in Post-IPO Equity - Pear Therapeutics
Sarissa Capital Management
Sarissa Capital Management investment in Post-IPO Equity - Pear Therapeutics
dRx Capital
dRx Capital investment in Post-IPO Equity - Pear Therapeutics
Arboretum Ventures
Arboretum Ventures investment in Post-IPO Equity - Pear Therapeutics
Jazz Venture Partners
Jazz Venture Partners investment in Post-IPO Equity - Pear Therapeutics
Pilot House Ventures
Pilot House Ventures investment in Post-IPO Equity - Pear Therapeutics
Palantir Capital
Palantir Capital investment in Post-IPO Equity - Pear Therapeutics
Official Site Inspections
http://www.peartherapeutics.com Semrush global rank: 1.47 M Semrush visits lastest month: 18.67 K
- Host name: 2.217.239.35.bc.googleusercontent.com
- IP address: 35.239.217.2
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Pear Therapeutics"
Pearl Therapeutics - Crunchbase Company Profile
Pearl Therapeutics is developing unique dual and triple combination products for the treatment of widely prevalent respiratory diseases, including chronic …See details»
Pear Therapeutics - Crunchbase Company Profile & Funding
Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.See details»
Pear Therapeutics 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Pear Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
AstraZeneca to acquire Pearl Therapeutics to strengthen …
Monday, 10 June 2013 AstraZeneca announced today that it has entered into a definitive agreement to acquire Pearl Therapeutics, a privately held company based in Redwood City, …See details»
Pearl Therapeutics 2025 Company Profile: Valuation, Investors ...
Information on acquisition, funding, cap tables, investors, and executives for Pearl Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Pear Therapeutics Company Profile - Office Locations ... - Craft
Jun 20, 2023 See insights on Pear Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Pear Therapeutics | Company Overview & News - Forbes
Before any organization pursues a digital transformation, they must first build three macro transformation pillars: culture, talent and technology.See details»
Pearl Therapeutics - VentureRadar
Pearl Therapeutics is a privately held company developing combination therapies for the treatment of highly prevalent respiratory diseases, including chronic obstructive pulmonary …See details»
Pear Therapeutics Company Profile: Overview and Full News Analysis
Pear Therapeutics is a Massachusetts-based company that operates in the digital therapeutics market. They specialize in developing prescription digital therapeutics to treat various diseases …See details»
Pear Therapeutics to Become a Public Company and Expand its …
Jun 22, 2021 Pear Therapeutics to Become a Public Company and Expand its Leadership Position in Prescription Digital TherapeuticsSee details»
Pearl Therapeutics Corporate Profile - The Lab Rat
Pearl Therapeutics is focused on developing combination therapies for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and other chronic respiratory diseases.See details»
Pear Therapeutics - Overview, News & Similar companies - ZoomInfo
View Pear Therapeutics (pear.dev.mk3creative.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Pearl Therapeutics Appoints Charles Bramlage President and Chief ...
Feb 25, 2011 Founded in 2006, Pearl Therapeutics is privately held and backed by 5AM Ventures, Clarus Ventures, New Leaf Ventures and Vatera Healthcare. For more information, …See details»
Pearl Therapeutics, Inc. (Pearl Therapeutics, Inc.) - 药物管线_专利_ …
了解Pearl Therapeutics, Inc. (Pearl Therapeutics, Inc.)公司的药物管线，治疗领域，技术平台，以及它的62项临床试验, 6篇新闻和17篇文献，疾病领域:免疫系统疾病，感染，技术平台:小分子 …See details»
TM - 5amventures.com
“The TiE organization’s recognition of Pearl is yet another validation of the accomplishments our scientists have made in the field of pulmonary drug product and technology development,” …See details»
A Brief History of Pear Therapeutics
Oct 2, 2024 A Brief History of Pear Therapeutics Founded in 2013, Pear Therapeutics has rapidly emerged as a leader in the digital therapeutics space, revolutionizing the way we …See details»
Who Owns Pear Therapeutics – CBM
Oct 2, 2024 Deep in the world of digital therapeutics, Pear Therapeutics stands out as a pioneering company revolutionizing the healthcare industry. But who truly owns this innovative …See details»
Pearl Therapeutics, Inc. | Insights
May 24, 2023 Latest on Pearl Therapeutics, Inc. Already A Biomedtracker Subscriber?You have access to the full company record through your subscription.See details»
Pear Therapeutics apps sell for $6M in post-bankruptcy auction
May 19, 2023 Less than two years after Pear Therapeutics went public in a SPAC deal worth $1.6 billion, its assets were sold in an auction for just $6 million.See details»
Pearl Therapeutics' PT003 Combination Therapy for COPD …
Dec 1, 2010 Pearl Therapeutics' PT003 Combination Therapy for COPD Demonstrates Superior Bronchodilation Compared to Spiriva® and Foradil® in Randomized Phase 2b Study …See details»